MENU
Aim higher

INGA

Integrated Drug Discovery Pipeline for Next Generation Aptamers

Flexmers are next generation aptamers and provide a novel alternative to drug compounds. To enable a very quick and efficient process for flexmer development, ATDBio, Biaffin and FlexMers BV will combine their expertise to create an integrated drug discovery pipeline for flexmers.
Acronym: 
INGA
Project ID: 
8 370
Ranking: 
35
Cut-off: 
10
Start date: 
01-09-2013
Project Duration: 
36months
Project costs: 
2 081 500.00€
Technological Area: 
Biology / Biotechnology
Market Area: 
Therapeutic